Ermac, Danna L.
HRN: 24-59-06 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/27/2024
AMPICILLIN 500MG (VIAL)
03/27/2024
04/03/2024
IV
300mg
Q6H
T/C CNS Infection
Checking Final Appropriateness
03/27/2024
GENTAMICIN 40MG/ML, 2ML (AMP)
03/27/2024
04/03/2024
IV
10mg
Q8H
T/C CNS Infection
Checking Final Appropriateness